Clinical Trials in Phoenix

Showing 401-420 of 7,960 trials

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

NCT06525259

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.

Diabetes Mellitus Type 2, Childhood-Onset

George Washington University3,600 participantsStarted Oct 2024

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +17 more locations

RECRUITINGPHASE1< 1 mile

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

NCT05433142

The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed or refractory clear cell renal cell carcinoma and to identify the minimum safe and biologically active dose and the recommended dose (RD).

Clear Cell Renal Cell Carcinoma

Xencor, Inc.307 participantsStarted Jun 2022

Phoenix, Arizona, United States • Duarte, California, United States • Sacramento, California, United States +20 more locations

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Find Trials by Condition in Phoenix

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

Trifecta-Lung cfDNA-MMDx Study

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes